Intratumoral Heterogeneity in Breast Cancer: A Case Report and Molecular Discussion
Journal Title: Middle East Journal of Cancer - Year 2018, Vol 9, Issue 4
Abstract
The emerging era of personalized medicine makes it increasingly important to consider intratumoral heterogeneity, which has been found in some breast cancer cases. However, its identification criteria, form of reporting, and subsequent effects on the clinical course of this disease remain controversial and not fully defined. Here, we report and discuss a case of breast invasive ductal adenocarcinoma with substantial intratumoral heterogeneity, discrepancy between Her2/neu immunostaining and in situ hybridization, and disparity between estrogen receptor status before and after neoadjuvant therapy.
Authors and Affiliations
Akbar Safaei, Ahmad Monabati, Maral Mokhtari, Mehdi Montazer
Keywords
Related Articles
- EP ID EP658158
- DOI -
- Views 72
- Downloads 0
Patients’ Experiences with the Degenerative Process of Cancer: A Content-analysis Study in Iran
Background: This study sought to provide a comprehensive understanding of cancer treatment refusal based on the experiences of patients, caregivers, and health care providers. Methods: In this qualitative research study,...
Association of Glutathione S-transferase Genes (M1 and T1) with the Risk of Acute Myeloid Leukemia in a Moroccan Population
Background: Acute myeloid leukemia, as most cancers, results from exposure to carcinogens and an impaired inherited individual capacity to eliminate xenobiotics. The present case-control study measures the relationship b...
Neoadjuvant Chemotherapy of Cervical Squamous Cell Carcinoma during Pregnancy: A Case Report
Squamous cell carcinoma is one of the common malignancies among women, especially in the third and fourth decades of life. Human papillomavirus is the most important cause of squamous cell carcinoma among women worldwide...
Clinicopathologic Features and Survival of Breast Cancer Subtypes in Northeast Iran
Background: Breast cancer can be categorized into different histopathological subtypes based on gene expression profiles. The aim of this study was to evaluate the clinicopathological features and overall survival (OS) o...
Role of SIZN1 in Esophageal Squamous Cell Carcinoma
Background: Bone morphogenetic proteins are a family of cytokines and growth factors that are involved in tumorigenesis. ZCCHC12 (SIZN1), as a transcriptional coactivator of bone morphogenetic protein signaling, is ident...